α-Adrenoceptor antagonists best choice for initial treatment of lower urinary tract symptoms related to benign prostatic hyperplasia

Author： Adis International Limited  

Publisher： Adis International

ISSN： 1172-0360

Source： Drugs & Therapy Perspectives, Vol.23, Iss.6, 2007-06, pp. : 9-11

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Alfuzosin: an α1-receptor blocker for the treatment of lower urinary tract symptoms associated with benign prostatic hyperplasia

By Elhilali Mostafa M  

Expert Opinion on Pharmacotherapy, Vol. 7, Iss. 5, 2006-04 ,pp. : 583-596

Informa Healthcare

Access to resources Recommend Favorite

The use of α-adrenoceptor antagonists in lower urinary tract disease

By Chess-Williams Russell  

Expert Opinion on Pharmacotherapy, Vol. 3, Iss. 2, 2002-02 ,pp. : 167-172

Informa Healthcare

Access to resources Recommend Favorite

Silodosin: a new subtype selective alpha-1 antagonist for the treatment of lower urinary tract symptoms in patients with benign prostatic hyperplasia

By Osman Nadir I   Chapple Christopher R   Cruz Francisco   Desgrandchamps François   Llorente Carlos   Montorsi Francesco  

Expert Opinion on Pharmacotherapy, Vol. 13, Iss. 14, 2012-10 ,pp. : 2085-2096

Informa Healthcare

Access to resources Recommend Favorite

Combined medical treatment using dutasteride and tamsulosin for lower urinary tract symptoms suggestive of benign prostatic hyperplasia

By Djavan Bob   Handl Markus Johannes   Dianat Saeid  

Expert Opinion on Pharmacotherapy, Vol. 11, Iss. 15, 2010-10 ,pp. : 2535-2547

Informa Healthcare

Access to resources Recommend Favorite

-Adrenoceptor Antagonists in the Treatment of Benign Prostatic Hyperplasia

By Cooper K.L.   McKiernan J.M.   Kaplan S.A.  

Drugs, Vol. 57, Iss. 1, 1999-01 ,pp. : 9-17

Adis International

Access to resources Recommend Favorite